Dana-Farber Cancer Institute has agreed to pay $15 million in a federal settlement, as the Boston research giant admits that researchers mispresented data and images in scientific journal articles.
The settlement resolves allegations that Dana-Farber made false statements related to National Institutes of Health research grants.
Two Dana-Farber scientists — or individuals under their supervision — were accused of using inaccurate or altered data or images in publications that were supported by NIH-funded awards, or in grant applications that resulted in federal funding for additional research.
This settlement comes nearly two years after Dana-Farber Cancer announced it was retracting six studies and correcting 31 others, as local scientists faced “data forgery” allegations for their cancer research.
As part of this DOJ settlement announced on Tuesday, Dana-Farber admitted that publications reused images to represent different experimental conditions; duplicated images to represent different testing conditions, mice, and/or timepoints; or rotated, magnified, or stretched images.
Dana-Farber also admitted that a supervising researcher failed to exercise sufficient oversight over the researchers responsible for these publications, and that Dana-Farber spent funds from six NIH grants for these publications that were unallowable.
Another researcher received four NIH grants after submitting grant applications that discussed a journal article authored by the researcher, but did...
Shoppers will now have a year to submit those rebate forms. Menards will pay Minnesota and nine other states millions to settle claims the company used deceptive advertising to promote its longstan...